Shionogi Pharma

Shionogi Pharma is a Japanese contract development and manufacturing organization (CDMO) and a wholly-owned subsidiary of the global pharmaceutical company Shionogi & Co., Ltd. Headquartered in Osaka, the company was established in 2019 to consolidate the group's manufacturing, analytical, and supply chain operations into a specialized service provider. Shionogi Pharma offers end-to-end solutions for drug substance and drug product development, specializing in small molecules, peptides, and highly potent active pharmaceutical ingredients (HPAPIs). A key differentiator for the company is its leadership in continuous manufacturing technology, which aims to streamline production and enhance quality control. In addition to supporting its parent company's portfolio in infectious diseases and CNS, Shionogi Pharma provides manufacturing services to a diverse range of global pharmaceutical and biotech clients. The company operates multiple GMP-compliant facilities across Japan, ensuring high-quality supply for both clinical and commercial stages.